MCD
65
2
T
51
6
CVX
32
3
AAL
62
6
TMO
52
-2
MLM
61
7
NTRS
62
5
LEN
61
2
KHC
47
2
KEY
55
2
CI
66
7
DD
42
2
OKE
52
3
FSLR
47
3
DIS
56
7
NOC
45
5
ORCL
65
2
HCA
68
6
LLY
59
3
AXP
73
3
MCD
65
2
T
51
6
CVX
32
3
AAL
62
6
TMO
52
-2
MLM
61
7
NTRS
62
5
LEN
61
2
KHC
47
2
KEY
55
2
CI
66
7
DD
42
2
OKE
52
3
FSLR
47
3
DIS
56
7
NOC
45
5
ORCL
65
2
HCA
68
6
LLY
59
3
AXP
73
3
Financhill
Back

ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN Vs. Kymera Therapeutics Industry Stock Comparison

Buy
66

MVRL
ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN

Last Price:
17.76
Seasonality Move:
15.27%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
66
ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN (MVRL) is a Buy

Is ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN a Buy, Sell or Hold?

  • The current ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN [MVRL] share price is $17.84. The Score for MVRL is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MVRL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MVRL Stock Price Chart

What is ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN's stock price today?

  • The ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN share price today is $17.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MVRL is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MVRL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.62 - 18.64) Sell
Bollinger Bands (100): (16.96 - 18.28) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

MVRL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.56 Buy
20-day SMA: 18.03 Sell
50-day SMA: 17.91 Sell
200-day SMA: 17.53 Buy
8-day EMA: 17.63 Buy
20-day EMA: 17.84 Buy
50-day EMA: 17.88 Sell
200-day EMA: 17.83 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN Earnings Growth & MVRL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ETRACS Mnthly Py 1.5X Lvgd Mtg REIT ETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):